4 Results for "

abnormal cellular proliferation

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "abnormal cellular proliferation" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-16191
CAS No.: 1233948-35-0
ELR510444 is an orally active tubulin inhibitor with an IC50 of 10 μM. ELR510444 binds to the colchicine-binding site on β-tubulin, inhibits tubulin assembly, depolymerizes microtubules and blocks HIF activity. ELR510444 induces cellular microtubule loss, abnormal mitotic spindle, mitotic arrest, apoptosis, morphological changes in tumor endothelial cells, and inhibits cancer cell proliferation, angiogenesis and tumor growth. ELR510444 can be used in research related to various cancers such as renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-146033
CAS No.: 331851-78-6
Target:  

HPV

Research Areas:  

Cancer

HPV18-IN-1 (Compound H1) is a potent inhibitor of HPV18. HPV18-IN-1 prevents cervical cancer cells from premature cell procession and abnormal proliferation. HPV18-IN-1 supresses E7-Rb-E2F cellular pathway and DNA methylation. HPV18-IN-1 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-145947
CAS No.: 2704616-86-2
Research Areas:  

Cancer

PROTAC BRD9 Degrader-5 is a BRD9 PROTAC degrader. PROTAC BRD9 Degrader-5 is used in research on acute myeloid leukemia, rhabdoid tumor, synovial sarcoma, and multiple myeloma .
loading...
    loading...
Cat. No.: HY-153421
CAS No.: 2242753-66-6
Research Areas:  

Cancer

PRMT5-IN-28 (compound 36) is an inhibitor of protein arginine methyltransferase 5 (PRMT5) enzyme. Protein arginine methylation is a common post-translational modification involved in gene transcription, mRNA splicing, DNA repair, protein cellular localization, cell fate determination and signal transduction, etc. Abnormal PRMT5 can promote cancer cell proliferation, resist apoptosis, enhance invasion and metastasis, and affect immune escape .
loading...
    loading...